Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
7.84
+0.04 (0.51%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $866.02 million as of December 20, 2024. Its market cap has increased by 14.66% in one year.
Market Cap
866.02M
Enterprise Value
538.30M
1-Year Change
14.66%
Ranking
Category
Stock Price
$7.84
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $866.02M, an increase of 596.88%. That is a compound annual growth rate of 54.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 866.02M | 71.01% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 900.40M |
| ArriVent BioPharma | 897.69M |
| Aveanna Healthcare Holdings | 896.56M |
| AMN Healthcare Services | 878.36M |
| Prothena Corporation | 872.24M |
| Immatics | 858.17M |
| uniQure | 851.06M |
| AbCellera Biologics | 844.75M |